Terminchart Intercept Pharmaceuticals, Inc.
Anstehende Termine für Intercept Pharmaceuticals, Inc.
Zurückliegende Termine für Intercept Pharmaceuticals, Inc.
13.11.2023 19:00 | American Association for the Study of Liver Diseases Conference - Poster Number #4545-C |
13.09.2023 21:10 | Baird Global Healthcare Conference |
11.09.2023 17:00 | H.C. Wainwright Global Investment Conference |
02.08.2023 14:30 | Q2 2023 Präsentation des Ergebnisses |
02.08.2023 13:00 | Q2 2023 Ergebnisveröffentlichung |
24.06.2023 09:00 | European Association for the Study of the Liver Congress - Abstract #2443 |
23.06.2023 14:30 | OCA FDA Approval Call |
23.06.2023 09:00 | European Association for the Study of the Liver Congress - Abstract #2321 |
23.06.2023 09:00 | European Association for the Study of the Liver Congress - Abstract #2349 |
23.06.2023 09:00 | European Association for the Study of the Liver Congress - Abstract #1518 |
23.06.2023 08:45 | European Association for the Study of the Liver Congress - Abstract #2495 |
21.06.2023 09:00 | European Association for the Study of the Liver Congress - Abstract #1522 |
21.06.2023 09:00 | European Association for the Study of the Liver Congress - Abstract #1505 |
21.06.2023 | European Association for the Study of the Liver Congress |
07.06.2023 | Jefferies Global Healthcare Conference |
24.05.2023 20:00 | Jahreshauptversammlung |
19.05.2023 | Gastrointestinal Drugs Advisory Committee Meeting |
27.04.2023 14:00 | Q1 2023 Präsentation des Ergebnisses |
27.04.2023 13:00 | Q1 2023 Ergebnisveröffentlichung |
14.03.2023 | Barclays Global Healthcare Conference |